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ABSTRACT
Objective To investigate the cost-effectiveness of 
exercise therapy in the treatment of patients with non-
specific neck pain and low back pain.
Design Systematic review of economic evaluations.
Data sources The search was performed in 5 clinical 
and 3 economic electronic databases.
Eligibility criteria for selecting studies We 
included economic evaluations performed alongside 
randomised controlled trials. Differences in costs and 
effects were pooled in a meta-analysis, if possible, and 
incremental cost-utility ratios (ICUR) were descriptively 
analysed.
Results Twenty-two studies were included. On average, 
exercise therapy was associated with lower costs and 
larger effects for quality-adjusted life-year (QALY) in 
comparison with usual care for subacute and chronic low 
back pain from a healthcare perspective (based on ICUR). 
Exercise therapy had similar costs and effect for QALY in 
comparison with other interventions for neck pain from a 
societal perspective, and subacute and chronic low back 
pain from a healthcare perspective. There was limited 
or inconsistent evidence on the cost-effectiveness of 
exercise therapy compared with usual care for neck pain 
and acute low back pain, other interventions for acute 
low back pain and different types of exercise therapy for 
neck pain and low back pain.
Conclusions Exercise therapy seems to be cost-
effective compared with usual care for subacute and 
chronic low back pain. Exercise therapy was not (more) 
cost-effective compared with other interventions for 
neck pain and low back pain. The cost-utility estimates 




Neck pain and low back pain are common condi-
tions, associated with high levels of disability, absen-
teeism and high socioeconomic costs.1–5 Neck pain 
and low back pain are leading causes of years lived 
with disability.3 Total annual expenses related to 
low back pain alone in the UK are about £12 billion, 
and in the USA indirect costs are US$7.4 billion.6 In 
the Netherlands, total annual societal costs of neck 
pain were estimated at US$686 million.7
As neck pain and low back pain are important 
global health problems, there is a need to consider 
the effectiveness of treatments for improving symp-
toms. Clinical practice guidelines recommend exer-
cise therapy in the treatment of patients with neck 
pain and low back pain.8–11 Exercise therapy may 
reduce pain and increase flexibility, strength, endur-
ance and cardiovascular conditioning.12–15
Given limited financial resources, knowledge 
regarding the relative efficiency of treatments 
would help decision makers prioritise resources. 
Economic evaluations, in which the incremental 
effects and incremental costs of two or more inter-
ventions are compared,16 can inform resource 
decision-making. The European Union’s ‘Research 
Agenda for Health Economic Evaluation’ (RAHEE) 
project examined evidence gaps about the cost-ef-
fectiveness of treatments for the 10 highest burden 
conditions in Europe.17 18 The RAHEE project iden-
tified the need for further high-quality economic 
evaluations about cost-effectiveness of exercise 
therapy for patients with neck pain and low back 
pain due to the lack of evidence.17 18 Therefore, the 
present study aimed to analyse current evidence to 
identify if exercise therapy is a cost-effective treat-
ment for non-specific neck pain and low back pain.
METhODS
Inclusion criteria
We included economic evaluations (including 
cost-effectiveness, cost-utility, cost-minimisation 
and cost-benefit analysis) performed alongside 
randomised controlled trials. Patients with non-spe-
cific neck pain (ie, pain in the cervical region, with 
or without radiation to the shoulder region or 
upper extremities, including whiplash disorders)19 
and low back pain (ie, pain in the region between 
the costal margins and the inferior gluteal fold, with 
or without radiation to the lower extremities)20 21 
were included. Studies including multiple pain loca-
tions without separately reporting results for neck 
pain and low back pain were excluded.
We considered any type of exercise therapy 
(eg, strengthening, endurance, aerobic, stretching, 
stabilisation, coordination, functional and neuro-
muscular exercises) performed individually or in a 
group. The exercise therapy could be supervised or 
unsupervised. Studies evaluating exercise therapy 
combined with other treatments were excluded 
unless exercise therapy was evaluated separately 
or was the main treatment. The comparator was 
no treatment, usual care, other types of inter-
vention (manual therapy, physiotherapy, cogni-
tive behavioural approach) and different types of 
exercise.
The primary outcome was the incremental cost-
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(QALY)) and the secondary outcomes were incremental cost-ef-
fectiveness ratios including any type of clinically relevant 
outcome measure reported in the studies (eg, pain intensity, 
disability, global perceived effect/recovery). We also included 
studies that measured effects and costs, but did not calculate an 
incremental cost-effectiveness ratio.
Search methods
The search was conducted in the following electronic databases: 
PUBMED, EMBASE, CINAHL, Cochrane Central Register 
of Controlled Trials, PEDro, EconLit, British National Health 
Services Economic Evaluation Database (NHSEED) and HTA. 
Thus, the protocol of this study registered previously (PROS-
PERO registration: CRD42017059025) was slightly modified. 
The clinical database CINAHL and the economic database HTA 
were added to the search strategy, and the economic database 
EURONHEED was excluded because it is not updated anymore. 
The electronic search terms were derived from the search strat-
egies of the Cochrane Back and Neck Group22 and NHSEED.23 
The complete EMBASE search strategy is presented in online 
supplementary appendix 1. We searched all databases from 
inception to 12 April 2017. In addition to the electronic search, 




Two reviewers (GCM and MvT) independently conducted the 
study selection process, first considering title and abstract, and 
then the full paper. Disagreements between reviewers were 
resolved first by discussion and then by arbitration of a third 
reviewer (JvD), if disagreements persisted. We included only 
full-text papers, and there was no restriction for date of publica-
tion and language.
Data extraction and management
Data were extracted by two independent authors (GCM and 
MvT/JvD). A customised data extraction sheet was used to 
extract bibliometric data (ie, author, year of publication and 
language), characteristics of participants (ie, location of pain, age 
and sample size), description of the interventions (ie, types of 
interventions, comparisons, frequency, intensity and duration), 
details of the economic evaluation (ie, country, currency, type and 
perspective of the economic evaluation, time horizon, willing-
ness to pay, reference year and discounting), outcomes assessed 
(ie, clinical outcomes, instruments, duration of follow-up assess-
ments, type of direct and indirect costs) and study results (ie, 
cost-effectiveness: differences in clinical and costs outcomes and 
incremental cost-effectiveness ratios).
Assessment of the risk of bias of the included studies
Two review authors (GCM and MvT/CL) independently 
conducted the assessment of the risk of bias. Disagreements 
were solved first by discussion and then by arbitration of a third 
reviewer (JvD), if disagreements persisted. The assessment of 
the risk of bias of the randomised controlled trial design was 
evaluated using the criteria from the Cochrane Back and Neck 
Group with 13 items.22 24 25 Each item was scored as ‘yes’, ‘no’ 
or ‘unclear’. Studies that met at least 6 or more of the 13 criteria 
were considered as having a low risk of bias.24 26 We opted to use 
the Consolidated Health Economic Evaluation Reporting Stan-
dards statement with 24 items, which is a report checklist devel-
oped to assess methodological quality, to evaluate risk of bias of 
economic evaluations.27 However, items 15 (choice of model), 
16 (assumptions) and 18 (study parameters) that evaluate studies 
with modelling methods were excluded. The possible answer 
to each item was ‘yes’, ‘no’ or ‘not applicable’. Items 4 (target 
population and subgroups), 7 (comparators), 8 (time horizon) 
and 11 (measurement of effectiveness) were scored ‘yes’ even if 
the studies did not include information on why population and 
comparators were chosen, why time horizon was appropriate, 
and why the single study was a sufficient source of clinical effec-
tiveness data. We judged studies that fulfilled at least 14 of the 
21 items as being at low risk of bias.
All publications related to the included studies (published 
protocols or clinical studies) were used to inform the risk of bias 
assessment and data extraction.
Data synthesis
Pain intensity and disability data were recorded, in which lower 
scores indicate improved effects. Differences in costs and effects 
were pooled in a meta-analysis, if possible, and incremental 
cost-effectiveness ratios were descriptively analysed. Results 
of the studies conducted with different times (eg, 6 months 
vs 1 year) were not combined in the meta-analysis. We used a 
random effect meta-analysis model. The assessment of heteroge-
neity was based on the I2 statistic.28 If substantial heterogeneity 
was present (I2>50%), we tried to find an explanation for this 
heterogeneity. If we did not find an explanation for this statis-
tical heterogeneity, we pooled the data, but were careful with 
interpretation of the results.
All costs were converted to Euros and Pound Sterling 
using purchasing power parities.29 Furthermore, all mone-
tary values were converted to the same reference year (2017) 
using consumer price indices for Euros30 and for Pound Ster-
ling.31 We used the threshold set by the UK’s National Institute 
for Health and Clinical Excellence (NICE) as an indicator for 
cost-effectiveness.32 33 That is, if an intervention had an incre-
mental cost-effectiveness ratio lower than £20 000 (€22 852) 
per QALY gained, the intervention was deemed as cost-effective 
compared with a comparator treatment. The intervention was 
also considered cost-effective when it was more effective and less 
costly compared with a comparator treatment. The intervention 
was not considered cost-effective when it was less effective and 
more costly compared with a comparator treatment or had an 
incremental cost-effectiveness ratio above £20 000 (€22 852) per 
QALY gained.
RESulTS
Characteristics of included studies
After screening the 9158 unique records found in the search, 
a total of 22 studies were included in the review (figure 1). 
Characteristics of included studies are described in online 
supplementary appendix 2. Five studies included participants 
with neck pain,34–38 16 studies included participants with low 
back pain39–54 and 1 study included participants with neck pain 
and low back pain.55 The number of participants included in 
the studies varied from 80 to 1287. Eight studies included 
acute (<6 weeks),35 38 39 42 49 51 54 55 and 16 studies subacute 
(6–12 weeks) and chronic (>12 weeks)34–36 38 40 41 43–48 50 52 53 55 
neck pain and low back pain. Most studies were conducted in 
Europe.34 35 37–39 41 43–55 One study was conducted in Switzer-
land,45 one study in Norway,52 three studies in Sweden,37 39 49 
six studies in the Netherlands,34 35 38 46 50 53 eight studies in the 
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Figure 1 Flow of systematic review.
Five studies36 37 43 47 55 applied the healthcare and societal 
perspective, one study39 applied the societal and employer 
perspective, one study46 applied the healthcare and employer 
perspective, six studies34 35 38 45 50 53 applied the societal perspec-
tive only and three studies44 48 51 applied the healthcare perspec-
tive only. Six studies40–42 49 52 54 did not report the perspective. 
If the applied perspective was not specifically mentioned, we 
assumed that studies that reported direct healthcare costs only 
were conducted from a healthcare perspective,40–42 and studies 
that also reported indirect costs were conducted from a soci-
etal perspective.49 52 54 Five studies37 40–42 54 did not calculate an 
incremental cost-effectiveness or cost-utility ratios.
Fifteen studies conducted a cost-utility anal-
ysis34–36 38 39 41 43–45 47 48 50 51 53 55; utilities were measured in 
terms of QALYs. Nine of these studies also conducted a cost-ef-
fectiveness analysis34–36 38 41 47 48 50 53 and clinical outcomes 
were measured in terms of pain intensity,34–36 41 48 53 number of 
days in pain,47 disability34–36 38 41 47 48 50 53 and global perceived 
recovery.34 35 38 53 Four studies37 40 44 54 conducted a cost-ef-
fectiveness analysis only and three studies46 49 52 conducted a 
cost-benefit analysis only.
Quality assessment
Risk of bias of the trial design
Five studies39 41 49 52 54 were at high risk of bias. None of the 
studies34–55 blinded assessors, patients or care providers. Four 
studies39 49 51 52 did not adequately report randomisation proce-
dures, six studies37 39 41 42 49 52 did not have an adequate allocation 
concealment and nine studies38–41 44 45 47 49 51 had a high drop-out 
rate. In three studies,39 49 54 groups were not similar at baseline. 
Eight studies39–41 47 49 51 52 54 did not report information on coint-
erventions and in two35 37 studies cointerventions were different 
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compliance and in eight studies34 40 41 43 45 48 50 53 compliance was 
not acceptable (table 1).
Risk of bias in the economic evaluation
Eight studies37 40–42 48 49 52 54 were at high risk of bias. Items 
1 (title),40–43 46 48 54 2 (abstract),35 37 39–42 44 46 48–50 52 54 55 6 
(perspective),37 40 42 46 49 52 54 12 (measurement and valuation 
of preference-based),35 41 44 48 50 13 (estimating recourses and 
costs),37 40–42 45 49 52 54 14 (currency, price date and conver-
sion),35 37 40 41 46 48 52 54 17 (analytical methods),37 40 42 44 48 49 52 54 
19 (incremental costs and outcomes),37 40–42 44 49 52 54 and 20 
(characteristics uncertainty)39 44 45 were most frequently failed. 
Five studies37 42 44 46 52 used a follow-up duration longer than 
12 months, but only one of those studies44 reported using 
discounting (table 2).
COST-EFFECTIvEnESS OF ExERCISE ThERApy
The results of the included studies for the cost-utility analysis are 
described in this session. The results of the included studies for 
cost-effectiveness analysis are presented in online supplementary 
appendix 3.
Exercise therapy compared with usual care
Neck pain
Two studies were identified.35 37 A meta-analysis could not be 
performed, because the studies evaluated different time horizons.
Based on cost-utility analysis from a societal perspective, exer-
cise therapy was associated with a cost of £−3421 (€−3840) per 
QALY gained (ie, cost-effective).35
Rosenfeld et al37 did not perform a cost-utility analysis.
Acute low back pain
Four studies were identified.39 42 49 54 A meta-analysis could not 
be performed, because the studies evaluated different clinical 
outcomes and did not present mean or SD for costs.
Based on cost-utility analysis, exercise therapy was not signifi-
cantly more effective than usual care for QALYs.39 The mean 
total societal cost was £1779 (€1969) for exercise therapy and 
£3787 (€4191) for usual care.39 The incremental cost-utility 
ratio was £4712 (€5214) per QALY gained from the employer’s 
perspective and £−10 874 (€−12 032) per QALY gained from 
the societal perspective (ie, cost-effective).39
Seferlis et al,49 Cherkin et al42 and Wright et al54 did not 
perform a cost-utility analysis.
Subacute and chronic low back pain
Five studies compared exercise therapy with usual care.43 45–47 51
Meta-analyses were conducted for QALY,43 45 51 and health-
care costs43 46 47 51 at 12 months (figure 2). There was no statis-
tically significant difference in QALYs (mean difference: 0.03, 
95% CI −0.01 to 0.06). From a healthcare perspective, the costs 
of exercise therapy were significantly higher than usual care 
(mean difference: £168, 95% CI 61 to 275; or mean difference: 
€176, 95% CI 64 to 288).
Based on cost-utility ratio from a societal perspective, there 
was £82 657 (€88 965) per QALY gained for the comparison 
between exercise therapy and usual care (ie, not cost-effective).45
Based on cost-utility ratio from a healthcare perspective, 
there was £3760 (€3874) per QALY gained for the comparison 
between exercise therapy and usual care (ie, cost-effective).47 
Based on cost-utility ratio from a healthcare perspective, there 
was an incremental increase of £11 649 (€12 293) per QALY 
gained (ie, cost-effective) for exercise therapy plus usual care 
compared with usual care alone.51
Based on cost-utility ratio from the healthcare perspective, 
there was £16 267 (€17 447) per QALY gained and exercise 
therapy was dominant from the societal perspective (ie, less 
costly and more effective).43
Hlobil et al46 did not perform a cost-utility analysis.
Exercise therapy compared with other type of intervention
Exercise therapy versus manual therapy
Neck pain >2 weeks
Four studies34–36 38 compared exercise therapy with manual 
therapy (manipulation and mobilisation).
Meta-analyses were conducted for QALY,34–36 38 and societal 
costs34–36 38 at 12 months (figure 3). There were no significant 
differences in QALY (mean difference: −0.02; 95% CI −0.04 
to 0.00) and costs (mean difference: £963, 95% CI −79 to 
2005; €1023, 95% CI −86 to 2132). A sensitivity analysis was 
performed to identify if studies conducted in different coun-
tries could influence the results. Including only three studies 
conducted in the Netherlands34–36 38 resulted in smaller differ-
ences (mean difference: £427, 95% CI −39 to 894; €434, 
95% CI −51 to 920), but these were also not statistically signifi-
cant. Meta-analyses for other clinical outcomes are described in 
online supplementary appendix 3.
From a societal perspective, there was an incremental cost-
utility ratio of £39 655 (€44 493) per QALY lost (ie, not 
cost-effective).35
From a societal perspective, exercise therapy had higher costs 
and smaller effects for QALY compared with manual therapy (ie, 
not cost-effective).34 Exercise therapy was associated with a cost 
of £14 740 (€16 138) per QALY lost in favour of manual therapy 
(ie, not cost-effective).38
From both the healthcare and societal perspective, exercise 
therapy was associated with higher costs and smaller effects for 
QALY in comparison with manual therapy.36
Acute low back pain
Two studies42 49 compared exercise therapy with manual 
therapy and performed only cost-effectiveness analysis (see 
online supplementary appendix 3 for results). A meta-analysis 
could not be performed, because the studies evaluated different 
time horizons, different clinical outcomes and did not present 
mean or SD for costs.
Subacute and chronic low back pain
The mean QALY was 0.63 for exercise therapy and 0.66 for 
manual therapy.51 The mean cost from the healthcare perspec-
tive was £682 (€719) for exercise therapy and £759 (€801) for 
manual therapy.51 The difference in costs and effects was not 
tested statistically, and an incremental cost-utility ratio was not 
presented.
Exercise therapy versus physiotherapy
Subacute and chronic low back pain
Five studies41 44 48 52 53 compared exercise therapy with phys-
iotherapy among patients with subacute and chronic low back 
pain.
A meta-analysis was performed for this comparison (figure 4). 
We pooled data from three studies for QALY.41 44 48 Exercise 
therapy had similar improvements to physiotherapy (QALY: 
0.01, 95% CI −0.07 to 0.05). The results for other clinical 
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Figure 2 Forest plots of comparison: exercise therapy vs usual care for subacute and chronic low back pain.
meta-analysis for costs could not be performed, because studies 
evaluated different time horizons.
From the healthcare perspective, exercise therapy had similar 
effect compared with physiotherapy for QALY. There were 
no significant differences in costs (£273 or €298 for exercise 
therapy and £480 or €525 for physiotherapy).41 There was an 
incremental cost-utility ratio of £−1416 (€−1456) per QALY 
lost for exercise therapy compared with physiotherapy (ie, less 
costly and less effective).44 There were no differences in QALY at 
12 months.48 Total mean costs were £1875 (€2053) for exercise 
therapy and £1426 (€1561) for physiotherapy.48
From the societal perspective, there was an incremental 
cost-utility ratio of £6759 (€6213) per QALY gained (ie, 
cost-effective).53
Torstensen et al52 did not perform a cost-utility analysis.
Exercise therapy versus cognitive behavioural approach
Neck pain and low back pain >2 weeks
Exercise therapy generated, on average, larger effects and higher 
costs compared with cognitive behavioural approach, but these 
differences were not statistically significant.55 The incremental 
cost-utility ratio was £1649 (€1683) per QALY gained from the 
healthcare perspective, and £7909 (€8078) per QALY gained 
from the societal perspective (ie, cost-effective).55 Exercise 
therapy had a probability of being cost-effective in comparison 
with cognitive behavioural of approximately 80% at a willing-
ness to pay of £1000 (€1142) per QALY gained.55
Chronic low back pain
Two studies were identified.44 50 A meta-analysis could not be 
performed, because the studies evaluated different time hori-
zons, different clinical outcomes and did not present mean or 
SD for costs.
There were no significant differences in effects of exercise 
therapy compared with cognitive behavioural approach and costs 
from a healthcare perspective. Based on the cost-utility ratio, 
exercise therapy was associated with higher costs and smaller 
effects than cognitive behavioural approach.44 Societal costs 
were £24 029 (23 621) or €24 488 (23 999) and mean QALY 
was 0.69 for exercise therapy, and £17 761 (20 661) or €18 100 
(21 055) and mean QALY was 0.72 for cognitive behavioural 
approach.50 There was no statistical analysis for the societal costs 
and QALY, there was no cost-utility ratio for the comparison of 
exercise therapy and cognitive behavioural approach.50
Exercise therapy versus different type of exercises
Chronic neck pain
Exercise therapy was associated with higher costs and smaller 
effects than home exercise alone.36 The incremental cost-utility 
ratio value was not reported.36
Acute low back pain
There was no difference between general exercises and yoga 
exercises for QALYs.39 On average, general exercises generated 
higher costs than yoga from the employer (£194 or €215) and 
societal perspective (£1436 or €1589), but these differences 
were not statistically tested.39
Subacute and chronic low back pain
Three studies were identified.40 48 52 A meta-analysis could not 
be performed, because the studies evaluated different time hori-
zons, different clinical outcomes and did not present mean or 
SD for costs.
From the healthcare perspective, there were no significant 
differences between stretching, aerobic and strengthening exer-
cises compared with walking at 12 months for QALYs.48 Total 
mean costs for exercise therapy were £1875 (€2053), and for 
walking were £1090 (€1194). No incremental cost-effectiveness 
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Figure 3 Forest plots of comparison: exercise therapy vs manual therapy for neck pain >2 weeks.




The aim of this systematic review was to investigate the 
cost-effectiveness of exercise therapy in the treatment of 
patients with non-specific neck pain and low back pain. 
We found 22 economic evaluations conducted alongside 
randomised controlled trials. No studies investigated the 
cost-effectiveness of exercise therapy in comparison with 
no treatment. This is not surprising, as no treatment is not 
considered a realistic option in clinical guidelines. Findings 
were limited or inconsistent for comparisons between exer-
cise therapy with usual care for neck pain and acute low back 
pain, other types of interventions for acute low back pain and 
different types of exercise in patients with neck pain or low 
back pain. Individual cost-utility ratios showed that exercise 
therapy was on average associated with lower costs and larger 
effects in comparison with usual care in patients with subacute 
and chronic low back pain from a healthcare perspective. In 
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Figure 4 Forest plots of comparison: exercise therapy vs physiotherapy for subacute and chronic low back pain.
perspective for exercise therapy compared with usual care in 
patients with subacute and chronic low back pain. However, 
in the meta-analyses we were unable to examine uncertainty 
concerning data. When we pooled the data, there were also 
no differences for costs and effects between exercise therapy 
and manual therapy for neck pain.
Strengths and weaknesses of the review
We conducted meta-analyses for clinical and costs outcomes. 
Many studies included in this systematic review did not 
report SD or SEs of the mean effects and costs, although 
this did not affect the primary outcome, the incremental 
cost-utility ratio. In addition, many studies did not statisti-
cally test cost and/or effect differences, preventing statistical 
pooling. Studies also evaluated different time horizons and 
clinical outcomes. Considering these issues, the main limita-
tion of our meta-analyses was the small number of studies per 
comparison. Although there are many randomised controlled 
trials investigating effectiveness of exercise therapy in the 
treatment of patients with neck pain and low back pain,56–58 
there are only few economic evaluations conducted alongside 
randomised controlled trials.
We combined results of a relatively small number of all 
available trials on exercise therapy. Thus, the results may not 
represent the real effects of exercise therapy. This is under-
scored by the fact that various systematic reviews56 58 59 of 
randomised controlled trials suggested that exercise therapy 
was more effective than usual care for pain intensity and 
disability at long-term in patients with chronic neck and low 
back pain. We did not find significant differences for this 
comparison in the meta-analyses of the subset of trials that 
also included an economic evaluation. It was not possible to 
conduct a meta-analysis for all comparisons and perspectives 
due to heterogeneity between the studies, lack of information 
and uncertainty surrounding costs or effects.
The number of economic evaluations was limited, which 
could introduce publication bias. Cost-effectiveness analysis 
might be only conducted if there is a difference in effects. 
Therefore, studies included in this systematic review could 
report an overestimation of the real effect. However, we did 
not find any differences in effects in the meta-analyses.
We assumed that costs in different countries are generalis-
able to a similar population. We applied a sensitivity analysis in 
which we included only three studies conducted in the Nether-
lands.34 35 38 The sensitivity analysis did not influence the results 
of meta-analysis.
A strength of this systematic review is that there were no 
restrictions for studies that did not include cost-effectiveness or 
cost-utility ratios (ie, incomplete economic evaluations), date 
of publication and language. We judged that most studies with 
incomplete economic evaluations37 40–42 54 were at high risk of 
bias. In future research, it would be prudent to only perform full 
economic evaluations to expand the evidence on cost-effective-
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What is already known?
 ► Neck pain and low back pain are leading causes of years 
lived with disability.
 ► Exercise therapy may reduce pain and disability of patients 
with neck pain and low back pain.
What are the findings?
 ► Exercise therapy seems to be cost-effective compared with 
usual care for subacute and chronic low back pain.
 ► Exercise therapy had similar costs and effects related to other 
interventions.
 ► Evidence around exercise therapy compared with usual care 
for neck pain and acute low back pain, other interventions 
for acute low back pain, and different types for neck pain and 
low back pain are still inconclusive.
little evidence for the cost-effectiveness of exercise therapy
Exercise therapy is a common intervention recommended 
by clinical practice guidelines for neck pain and low back 
pain,8 9 11 but there is still little evidence of its cost-effective-
ness. As evidence for exercise therapy suggests that differences 
in effects compared with other interventions are small or 
moderate for patients with neck pain and low back pain,56 58 59 
cost-effectiveness of treatments becomes more important in 
making decisions due to limited healthcare resources. There 
are two systematic reviews that investigated the cost-effec-
tiveness of conservative interventions for neck pain60 61 and 
three systematic reviews for low back pain.62–64 However, 
none of these conducted a meta-analysis to compare results of 
costs and effects of the studies included. Furthermore, these 
systematic reviews did not include studies with incomplete 
economic evaluation.40–42 46 49 52 54 Present review included 
all economic evaluations (complete and incomplete analyses) 
and also included recently published studies.36 38 48 Thus, it 
was possible to pool data and analyse all published economic 
evaluations.
Our results correspond with those of other systematic 
reviews60 61 on neck pain. Behavioural graded activity was 
not cost-effective (ie, similar costs and effects) compared 
with manual therapy for neck pain, and combined treatment 
(consisting of advice, exercise therapy and manual therapy) 
was not cost-effective compared with usual care plus exercise 
therapy for neck pain.60 Exercise therapy was cost-effective 
compared with usual care for neck pain, but combined treat-
ment (consisting of exercise therapy and manual therapy) was 
not.61 We found that home exercises plus manual therapy had 
lower costs and larger effects in comparison with home exer-
cises alone.
There is inconsistent and heterogeneous evidence,62 64 
although, exercise therapy may be a cost-effective interven-
tion compared with usual care for chronic low back pain.63 
We found that exercise therapy seems to be cost-effective 
compared with usual care, but the cost-effectiveness is similar 
in comparison with physiotherapy for subacute and chronic 
low back pain.
Future directions and implications
There remains a need for more high-quality economic evalu-
ations alongside randomised controlled trials to evaluate the 
cost-effectiveness of exercise therapy compared with usual 
care and other types of interventions for patients with acute, 
subacute and chronic neck pain and low back pain. Economic 
evaluations comparing exercise therapy with drugs and 
surgery for patients with neck and low back pain are urgently 
needed. We recommend adding an economic evaluation to any 
future randomised controlled trial. Collaboration with health 
economists or other researchers with expertise in the field of 
health economics/health technology assessment is beneficial. 
Researchers must also report on the uncertainty surrounding 
the estimates and statistically test cost and effect differences. 
These steps may also help guideline developers when they 
consider cost-effectiveness in treatment recommendations.
COnCluSIOnS
Exercise therapy seems to be cost-effective compared with 
usual care for subacute and chronic low back pain. Exercise 
therapy was not (more) cost-effective, and had similar costs 
and effects compared with other type of interventions for 
neck pain, and subacute and chronic low back pain.
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